2-deoxy-2-(F-18)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology

被引：20
作者：
Freebody, John [1 ,2 ]
Wegner, Eva A. [1 ,2 ]
Rossleigh, Monica A. [1 ,2 ]
机构：
[1] Prince Wales & Sydney Childrens Hosp, Dept Nucl Med, Barker St, Randwick, NSW 2031, Australia
[2] Prince Wales & Sydney Childrens Hosp, PET, Randwick, NSW 2031, Australia
来源：
WORLD JOURNAL OF RADIOLOGY | 2014年 / 6卷 / 10期
关键词：
Positron emission tomography; Computed tomography; Fluorodeoxyglucose F18; Paediatrics; Oncology; Technical issues; Dosimetry;
D O I：
10.4329/wjr.v6.i10.741
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Positron emission tomography (PET) is a minimally invasive technique which has been well validated for the diagnosis, staging, monitoring of response to therapy, and disease surveillance of adult oncology patients. Traditionally the value of PET and PET/computed tomography (CT) hybrid imaging has been less clearly defined for paediatric oncology. However recent evidence has emerged regarding the diagnostic utility of these modalities, and they are becoming increasingly important tools in the evaluation and monitoring of children with known or suspected malignant disease. Important indications for 2-deoxy-2-(F-18)fluoro-D-glucose (FDG) PET in paediatric oncology include lymphoma, brain tumours, sarcoma, neuroblastoma, Langerhans cell histiocytosis, urogenital tumours and neurofibromatosis type.. This article aims to review current evidence for the use of FDG PET and PET/CT in these indications. Attention will also be given to technical and logistical issues, the description of common imaging pitfalls, and dosimetric concerns as they relate to paediatric oncology. (c) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码：741 / 755
页数：15
相关论文
共 145 条
[1]   Langerhans cell histiocytosis: Current concepts and treatments [J].
Abla, Oussama ;
Egeler, R. Maarten ;
Weitzman, Sheila .
CANCER TREATMENT REVIEWS, 2010, 36 (04) :354-359
[2]  
Allen-Auerbach M, 2006, J NUCL MED, V47, P298
[3]   Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement [J].
Azouz, EM ;
Saigal, G ;
Rodriguez, MM ;
Podda, A .
PEDIATRIC RADIOLOGY, 2005, 35 (02) :103-115
[4]   The incremental value of 18F-FDG PET/CT in paediatric malignancies [J].
Bar-Sever, Zvi ;
Keidar, Zohar ;
Ben-Barak, Ayelet ;
Bar-Shalom, Rachel ;
Postovsky, Sergey ;
Guralnik, Luda ;
Ben Arush, Myriam W. ;
Israel, Ora .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (05) :630-637
[5]   Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma:: Comparative study [J].
Bar-Shalom, R ;
Yefremov, N ;
Haim, N ;
Dann, EJ ;
Epelbaum, R ;
Keidar, Z ;
Gaitini, D ;
Frenkel, A ;
Israel, O .
RADIOLOGY, 2003, 227 (02) :353-360
[6]  
Barrington SF, 1996, J NUCL MED, V37, P1127
[7]   Pilot study of F18-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: Correlation with conventional imaging, pathology and immunohistochemistry [J].
Begent, Joanna ;
Sebire, Neil J. ;
Levitt, Gill ;
Brock, Penelope ;
Jones, Kathy Pritchard ;
Ell, Peter ;
Gordon, Isky ;
Anderson, John .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (03) :389-396
[8]   FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas [J].
Benz, Matthias R. ;
Czernin, Johannes ;
Allen-Auerbach, Martin S. ;
Tap, William D. ;
Dry, Sarah M. ;
Elashoff, David ;
Chow, Kira ;
Evilevitch, Vladimir ;
Eckardt, Jeff J. ;
Phelps, Michael E. ;
Weber, Wolfgang A. ;
Eilber, Fritz C. .
CLINICAL CANCER RESEARCH, 2009, 15 (08) :2856-2863
[9]   Utilization of positron emission tomography in the management of patients with sarcoma [J].
Benz, Matthias R. ;
Tchekmedyian, Nishan ;
Eilber, Fritz C. ;
Federman, Noah ;
Czernin, Johannes ;
Tap, William D. .
CURRENT OPINION IN ONCOLOGY, 2009, 21 (04) :345-351
[10]  
Biasotti S, 2000, MED PEDIATR ONCOL, V35, P153, DOI 10.1002/1096-911X(200008)35:2<153::AID-MPO18>3.0.CO
12345678910